Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Revenue: 2011-2024

Historic Revenue for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $99.6 million.

  • Niagen Bioscience's Revenue rose 32.86% to $34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.7 million, marking a year-over-year increase of 36.04%. This contributed to the annual value of $99.6 million for FY2024, which is 19.18% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Revenue is $99.6 million, which was up 19.18% from $83.6 million recorded in FY2023.
  • Over the past 5 years, Niagen Bioscience's Revenue peaked at $99.6 million during FY2024, and registered a low of $59.3 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $83.6 million (2023), whereas its average is $85.1 million.
  • Data for Niagen Bioscience's Revenue shows a peak YoY increased of 28.01% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Niagen Bioscience's Revenue stood at $59.3 million in 2020, then grew by 13.82% to $67.4 million in 2021, then grew by 6.82% to $72.0 million in 2022, then rose by 15.99% to $83.6 million in 2023, then rose by 19.18% to $99.6 million in 2024.